Mind Medicine Australia welcomes consideration of changes to allow psychedelic therapy in the ACT
Mind Medicine Australia, 11 May, 2022
Mind Medicine Australia has welcomed consideration by the ACT Health Minister, Rachel Stephen-Smith, and the ACT Mental Health Minister, Emma Davidson, of legislative changes to allow psychedelic therapy in the ACT to treat mental illness.
Mind Medicine Australia Lodges New Applications for the Restricted Medical use of MDMA and Psilocybin Assisted Therapies for Patients with Treatment Resistant Mental Illnesses
Mind Medicine Australia, 17 March, 2022
Australia is experiencing a severe mental health epidemic, and this crisis is getting worse. Unfortunately, existing treatments only lead to remission for a minority of patients with depression and post-traumatic stress disorder and the psychiatric pharmaceuticals can cause dependence and nasty side effects for some patients. For this reason, Mind Medicine Australia is again seeking to reschedule the medical use of psilocybin and MDMA as part of therapy from Schedule 9 (prohibited substances) to Schedule 8 (controlled medicines) of the Poisons Standard.
Why is an Australian life less worthy than a Canadian’s?
Mind Medicine Australia, 09 February, 2022
Both Canada and Australia are battling a growing shadow pandemic of mental illness. Despite having world leading health care systems, both nations are facing an ever-increasing wave of mental illness, addictions and lives lost to suicide. On 4th January 2022, Health Canada announced that it will provide a pathway for physicians to obtain approvals for patients to access Psychedelic-Assisted Therapies through their Special Access Program. Australia has yet to implement a similar scheme.
New Polling by Mind Medicine Australia Reveals Over 60% of Australians Support Increased Access to Psychedelic Medicines
Mind Medicine Australia, 07 February, 2022
Mind Medicine Australia (MMA) is delighted to announce the findings of a sentiment poll we initiated through Essential Research last week.
Mind Medicine Australia joins global coalition launched to secure a rescheduling of psilocybin under the 1971 UN Convention on Psychotropic Substances
Mind Medicine Australia, 13 January, 2022
Today Mind Medicine Australia joins in the launch of the International Therapeutic Psilocybin Rescheduling Initiative (ITPRI), a global coalition working to promote and secure a rescheduling of psilocybin under the 1971 Convention on Psychotropic Substances.
Emyria to expand Real World Data assets for MDMA-assisted therapy trials by incorporating wearables monitoring
Emyria (ASX: EMD ) Press Release, 20 December, 2021, 15 December, 2021
Emyria’s phase 2b MDMA-assisted therapy trial for severe Post Traumatic Stress Disorder (PTSD), EMDMA-001, developed with registered charity Mind Medicine Australia (MMA), will be the first program to incorporate Cydelic technology and is expected to be one of the first programs in the world to incorporate remote patient monitoring within MDMA-assisted therapy.
TGA says NO again to psychedelic-assisted therapies.
Mind Medicine Australia, 15 December, 2021
Mind Medicine Australia’s Response to the Announcement of the TGA NOT to Reschedule the Medical Use of MDMA for Treatment Resistant PTSD and the Medical Use of Psilocybin for Treatment Resistant Depression as Part of Therapy.
Monash University announces establishment of the Neuromedicines Discovery Centre to Focus on Psychedelic-Assisted Therapies for the Treatment of Key Classes of Mental Illness
Mind Medicine Australia, 10 November, 2021
We are delighted that Monash University has announced the establishment of the Neuromedicines Discovery Centre (NDC) to focus on psychedelic-assisted therapies for the treatment of mental illness. This initiative was developed from a proposal put to Monash University by Mind Medicine Australia and our advocacy work with key stakeholders.
Mind Medicine Australia Launches Australia’s First Book of Psychedelic Healing Stories
Mind Medicine Australia, 18 October, 2021
Mind Medicine Australia (MMA) is releasing a new book sharing the psychedelic healing stories of 53 Australians, in their own words. Launched during Mental Health Month, this first Australian book of true stories further reinforces the life-changing and life-saving impact of psychedelic-assisted therapies for a range of mental illnesses and addictions.
Launching a Dedicated Training, Education and Clinical Services Organisation Focusing on Psychedelic Assisted Therapies for Mental Illness and the Developing Understanding of the Mind, Cognition and Human Consciousness
Mind Medicine Australia, 12 October, 2021
Mind Medicine Australia (MMA) and Integrated Psychology and Medicine (IPM) are delighted to announce the establishment of a new training, education and clinical services organisation called Mind Medicine Training and Education (MMTE).
Expert Review Findings Support the Therapeutic Use of Medicinal Psychedelics in Treating Mental Health Crisis
Mind Medicine Australia, 03 October, 2021
The findings of an expert panel reviewing the use of psychedelics in treating Australia’s mental health crisis, give strong support to such treatments being introduced at this stage on a case-by-case basis, under the supervision of the patient’s doctors and trained therapists.
TGA moves one step closer to rescheduling MDMA and Psilocybin in Australia
Mind Medicine Australia, 01 October, 2021
Yesterday, the TGA released the Independent Review that it had commissioned on the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of key mental health disorders.
Mind Medicine Australia to host Australia’s Inaugural International Summit on Psychedelic Therapies for Mental Illness online in November 2021
Mind Medicine Australia, 02 September, 2021
Mental health charity Mind Medicine Australia (MMA) is delighted to announce the inaugural International Summit on Psychedelic Therapies for Mental Illness and 2-day Introductory Workshop will take place between 17–20 November 2021 online.
Australia’s crisis of suffering accelerates while effective treatment remains blocked
Mind Medicine Australia, 25 August, 2021
Mind Medicine Australia is urgently calling for the Federal and State governments to enable psychedelic-assisted therapies to be used to treat severely ill patients who desperately need safe and effective treatments.
TGA appoints Independent Expert Panel on MDMA and psilocybin
TGA, 05 August, 2021
The Therapeutic Goods Administration (TGA) Scheduling Delegate (decision maker) has deferred the final decision on applications to down-schedule MDMA and psilocybin from schedule 9 (prohibited drug) to schedule 8 (controlled drug) pending a review into the therapeutic value, risks and benefits to public health outcomes for these substances. The Independent Expert Panel to undertake this review has now been established.
Mind Medicine Australia announces 10 scholarships to be made available to outstanding female health professionals from the Northern Rivers Region
Mind Medicine Australia, 23 June, 2021
Mind Medicine Australia is delighted to announce that it will offer 10 scholarships for its Certificate in Psychedelic-Assisted Therapies (CPAT) for female psychiatrists, GPs, physicians, nurses, psychologists, psychotherapists, social workers, counsellors and occupational therapists in the Northern Rivers Shire of NSW.
Legislative changes to allow psychedelic-assisted therapy treatments for mental illness patients in the ACT if first approved by the TGA
Mind Medicine Australia, 15 June, 2021
Mind Medicine Australia has proposed conservative legislative changes to allow psychedelic-assisted therapy to be used for the treatment of mental illness in the ACT where they have first been approved by the Therapeutic Goods Administration (TGA).
The Enormous “Elephant in the Room” in assessing the Government’s Budget Announcement of a $2.3 billion increase to Mental Health Funding
Mind Medicine Australia, 13 May, 2021
Mind Medicine Australia (MMA) welcomes the Government’s commitment to mental health and its drive to improve the mental health of Australians and reduce suicide rates. The increased funding for the sector announced in the Budget is an especially important part of this.
Emyria and Mind Medicine Australia to launch Psychedelic-Assisted Therapy Program (EMDMA-001) for PTSD
Mind Medicine Australia, 10 May, 2021
On Wednesday 5 May, Emyria (ASX:EMD) and Mind Medicine Australia announced their first psychedelic-assisted therapy care program (EMDMA-001) for sufferers of treatment resistant post-traumatic stress disorder (PTSD).
TGA Seeks Independent Review on Rescheduling of Psilocybin and MDMA as Part of Therapy in Medically Controlled Environments
Mind Medicine Australia, 08 April, 2021
The TGA announced that the Scheduling Delegate has decided to seek further advice in relation to Mind Medicine Australia’s applications to reschedule psilocybin and MDMA as part of therapy in medically controlled environments.
Your Psychedelic Healing Stories Can Help Change and Save Lives
Mind Medicine Australia, 24 March, 2021
We’re putting together a special book about psychedelics in Australia, the first of its kind – filled with incredible and inspirational stories of people who’ve changed their lives through psychedelic medicines like psilocybin and MDMA.
Australia's Federal system blocking psychedelic treatments for mental illness
Mind Medicine Australia, 17 March, 2021
Mind Medicine Australia welcomes the Government’s announcement to provide $15 million for the development of innovative therapies for mental illness.
Mind Medicine Australia urges TGA to reverse its Interim Decision on scientific and humanitarian grounds
Mind Medicine Australia, 10 March, 2021
Mind Medicine Australia has just made its final submissions to the TGA opposing their interim decision NOT to reschedule psilocybin and MDMA as Controlled Medicines. A comparison with other substances listed in Schedule 8 of the Poisons Standard indicates that this is the right schedule for the medical use of these substances in controlled medical environments.
Mind Medicine Australia Announces Second Screening of Acclaimed Film Fantastic Fungi in Byron Bay
Mind Medicine Australia, 08 March, 2021
Mind Medicine Australia is thrilled to announce our second screening of Fantastic Fungi at 6:30pm on Tuesday March 30th at Byron Theatre in Byron Bay followed by a Q & A Panel and conversation. This is a second screening as the first screening has sold out.
Mind Medicine Australia Announces First Ever Event In Canberra – Screening of the World Acclaimed Film Trip of Compassion
Mind Medicine Australia, 19 February, 2021
Mind Medicine Australia is thrilled to announce our first ever screening of Trip of Compassion at 6:30pm on Wednesday March 3rd at Palace Electric Cinema in Canberra followed by a Q&A Panel and discussion.
Mind Medicine Australia challenges TGA Interim Decision
Mind Medicine Australia, 17 February, 2021
Mind Medicine Australia urgently needs your support to ensure the Rescheduling Applications for the Medicinal Use of Psilocybin and MDMA are approved by the Government in Canberra.
Mind Medicine Australia Prepares to Contest TGA’s Interim Decision Not to Reschedule Psilocybin and MDMA for Medical Use as Part of Therapy for Key Mental Illnesses
Mind Medicine Australia, 03 February, 2021
Mind Medicine Australia prepares to contest TGA’s interim decision not to reschedule psilocybin and MDMA for medical use as part of therapy for key mental illnesses.
Mind Medicine Australia Anticipates Interim Decision Regarding Australia’s First Applications to Reschedule Psilocybin and MDMA for Medical Use as Part of Therapy for Key Mental Illnesses to be Announced on February 3
Mind Medicine Australia, 12 January, 2021
Mind Medicine Australia awaits the Therapeutic Goods Administration’s (TGA) interim decision on the rescheduling of psilocybin and MDMA to be used as part of clinical therapy for the treatment of major classes of mental illness. If approved, this would reclassify the medicines from Schedule 9 (Prohibited Substance) of the Standard for the Uniform Scheduling of Medicines and Poisons, to Schedule 8 (Controlled Medicine).
World Famous Author & Physician Dr Gabor Mate Joins Global and Australian Leaders on MMA Advisory Board
Mind Medicine Australia, 02 December, 2020
World Famous Author & Physician Dr Gabor Mate Joins More Than 55 Global and Australian Leaders on Mind Medicine Australia’s Advisory Board. Dr Gabor Mate joins a diverse group of global and Australian leaders including Anthropologist Dr Wade Davis CM (Canada), Islamic Scholar and Imam Mohammad Tawhidi, Founder and Director of the Beckley institute Amanda Feilding (UK), Psychedelics researcher Dr Robin Carhart-Harris (UK), Psychiatrist Tanveer Ahmed, Human Rights Lawyer Scott Leckie and many others.
ASX Media Release: Emyria partners with Mind Medicine Australia to develop national care program and data registry for psychedelic-assisted therapies
ASX, 19 November, 2020
Mind Medicine Australia partners with Emyria (ASX: EMD) to develop national care program and data registry for psychedelic-assisted therapies.
Australian charity paving the way in psychedelic-assisted therapy launches FREE online webinar series during Mental Health Month
Mind Medicine Australia, 12 October, 2020
World-leading experts are brought straight into Australia’s living rooms for discussion about the ground breaking opportunity psychedelic-assisted therapies offer us, and the solutions needed to address problems caused by long-term reliance on pharmaceuticals for mental health treatment.
Mind Medicine Australia Shines a Light on Breakthrough Therapies for Mental Health this Mental Health Month
Mind Medicine Australia, 08 October, 2020
Mind Medicine Australia Shines a Light on Breakthrough Therapies for Mental Health this Mental Health Month.
Covid-19 Significant Societal and Mental Health Impacts Highlights Urgent Need for Innovation in Treatments for Mental Illness
Mind Medicine Australia, 30 September, 2020
Mind Medicine Australia exists to help alleviate the suffering caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients. We already had a major mental health epidemic prior to this pandemic, and this is being severely exacerbated as noted. New treatments are urgently needed to heal those who have and are being damaged by this major crisis.
Mind Medicine Australia Submits Australian-First Application for the Rescheduling of Psilocybin and MDMA
Mind Medicine Australia, 01 September, 2020
Mind Medicine Australia has submitted Australia’s first applications to the Therapeutic Goods Administration (TGA) to reschedule Psilocybin and MDMAso that they can be more easily used as part of clinical therapies for the treatment of major classes of mental illness.
ACT Support for Breakthrough Psychedelic-assisted Mental Health Therapies in Upcoming Election
Mind Medicine Australia, 01 August, 2020
Mind Medicine Australia welcomes the announcement of the ACT Greens in supporting the development of psychedelic-assisted therapies for the treatment of mental illness in its recently announced drug law reform policy platform.
Mind Medicine Australia Announces First in Southern Hemisphere - Certificate in Psychedelic-Assisted Therapies
Mind Medicine Australia, 01 June, 2020
Mental health charity Mind Medicine Australia (MMA) has announced the, first of its kind in the southern hemisphere, Certificate in Psychedelic-Assisted Therapies (CPAT).
Mind Medicine Australia calls for URGENT Mental Health Innovation Taskforce to tackle the mental health pandemic sparked by Covid-19
Mind Medicine Australia, 06 April, 2020
Mental health charity Mind Medicine Australia (MMA) calls for and strongly supports all recommendations to form a Mental Health Innovation Taskforce to be immediately established in order to guide the government in planning the next steps to manage the increasing mental health pandemic triggered by Covid-19 and the recent bushfires tragedy.
Urgent Need to Establish a Government-Appointed Steering Group to Fast-Track Consideration of Medicine-Assisted Psychotherapies in Australia
Mind Medicine Australia, 24 February, 2020
Mind Medicine Australia (MMA), an Australian-registered charity established to support the development of research-backed and regulatory-approved medicine-assisted psychotherapy in Australia, has publicly released its written submission to the Australian Productivity Commission (APC) in relation to its current inquiry into mental health. The document can be read on the APC Commission website here.
Mind Medicine Australia celebrates its First Anniversary
Mind Medicine Australia, 12 February, 2020
Today, Mind Medicine Australia turns one year old! In our first year, we have made remarkable progress in growing public awareness of Medicine-Assisted Therapy in Australia. We are already seeing a paradigm shift in the curiosity, acceptance, and interest into the use of medicine-assisted therapy for depression, addiction, PTSD, obsessive-compulsive disorder, anorexia and other challenges in our communities.
MDMA-assisted psychotherapy for bushfire victims - Fast-tracked access needed for breakthrough PTSD treatment
Mind Medicine Australia, 30 January, 2020
It is estimated that 800,000 Australians suffer from post-traumatic stress disorder (PTSD). Mental health experts predict this staggering figure will rise sharply as a result of the trauma experienced by families and first responders who have had their lives or safety threatened by the catastrophic bushfires this summer.
Premiere Melbourne Screenings - Fantastic Fungi
Mind Medicine Australia, 13 January, 2020
Mind Medicine Australia is proud to the present the Melbourne premiere of Fantastic Fungi. An exploration of Mycelium that is the very foundation of life on this planet – not only for our species but for so many species on this Earth that we love and we can work with it to restore our planet.
Premiere Byron Bay Screening - Trip of Compassion
Mind Medicine Australia, 06 January, 2020
Mind Medicine Australia is thrilled to announce a screening of the acclaimed documentary Trip of Compassion in Byron Bay, NSW.
Mind Medicine Australia announces new appointment to Board of Directors
Non-Executive Director, Mind Medicine Australia, 21 November, 2019
The Hon Andrew Robb announces his appointment to the Board of Mind Medicine Australia.
Launch Media Release: Almost one in two Australians will be affected by mental illness in their lifetime
Mind Medicine Australia, 01 February, 2019
Psychedelic Medicines Could Provide an Effective and Ground-Breaking Treatment, says Mind Medicine Australia.